| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Rodman David Malcom serves as a Chief Medical Officer at MLYS. Across recent SEC filings that breaks down to 0 buys and 41 sells. Those positions are worth an estimated $1.4M at current prices.
Historically, Rodman David Malcom's trades have earned a middling insider score of 54/100 across 26 rated trades. Over a 12-month horizon, 27.3% of those trades were profitable, with an average 12-month return of -52.7%.
The biggest single holding is MLYS (~$1.4M) as Chief Medical Officer. The recent filings there lean toward selling, a net 770,567 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | MLYS Mineralys Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 8,518 | $32.56 | $277,339.14 | -6.4% | -19.3% | - | |
| Jan 5, 2026 | MLYS Mineralys Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 262,752 | $35.25 | $9,261,028.10 | -51.6% | -20.8% | - | |
| Oct 15, 2025 | MLYS Mineralys Therapeutics, Inc. | Chief Medical Officer | Sell | 10,369 | $43.01 | $445,982.10 | -12.7% | -24.0% | - | |
| Sep 15, 2025 | MLYS Mineralys Therapeutics, Inc. | Chief Medical Officer | Sell | 11,367 | $36.00 | $409,265.98 | -6.4% | -0.5% | - | |
| Aug 13, 2025 | MLYS Mineralys Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 11,365 | $12.93 | $146,986.95 | -10.9% | +247.4% | - | |
| Jul 14, 2025 | MLYS Mineralys Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 11,366 | $14.59 | $165,878.81 | -10.4% | +186.6% | +81.6% | |
| Jun 13, 2025 | MLYS Mineralys Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 11,366 | $14.60 | $165,931.10 | -10.1% | +159.5% | +64.9% | |
| May 14, 2025 | MLYS Mineralys Therapeutics, Inc. | Chief Medical Officer | Sell | 11,366 | $15.29 | $173,773.64 | -9.6% | -10.6% | +80.5% | |
| Apr 14, 2025 | MLYS Mineralys Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 11,366 | $14.53 | $165,185.14 | -4.7% | +7.9% | +91.2% | |
| Apr 1, 2025 | MLYS Mineralys Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 55,771 | $15.76 | $879,008.48 | -12.3% | -2.2% | +90.8% |